BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...May 22, 2019 doi:10.1126/scitranslmed.aav7325 CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute...
BioCentury | May 29, 2018
Preclinical News

IL-1 blockade to treat CAR T side effects

...RA, giant cell arteritis and certain forms of juvenile idiopathic arthritis. Elizabeth S. Eaton Kineret, anakinra (Interleukin-1ra (IL-1ra)) San Raffaele Scientific Institute Sloan...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Neurology

...published online Feb. 20, 2018 doi:10.1016/j.celrep.2018.01.089 CONTACT: Vania Broccoli, San Raffaele Scientific Institute, Milan, Italy email: broccoli.vania@hsr.it Hongjiang Li San Raffaele Scientific Institute Optic...
BioCentury | Mar 2, 2018
Preclinical News

Targeting IL-30 could treat prostate cancer

...treating the disease. The researchers, who are based at the University of Chieti-Pescara and the San Raffaele Scientific Institute...
...normal IL-30 expression and increased metastasis to the lungs, lymph nodes and bone marrow. Jaime De Leon San Raffaele Scientific Institute Prostate...
BioCentury | Oct 23, 2017
Preclinical News

Researchers identify new targets for DMD

...27, 2015) . In a separate study , researchers at the University of Milan and San Raffaele Scientific Institute...
...and collagen deposits, and by increasing measures of muscle oxidation. Allison Johnson istaroxime Mydicar Celladon Corp. Lee's Pharmaceutical Holdings Ltd. Rutgers University San Raffaele Scientific Institute ScinoPharm...
BioCentury | Oct 3, 2017
Distillery Therapeutics

Autoimmune disease

...published online Sept. 25, 2017 doi:10.1172/JCI92387 CONTACT: Gianvito Martino, San Raffaele Scientific Institute, Milan, Italy email: martino.gianvito@hsr.it Claire Quang San Raffaele Scientific Institute Transforming...
BioCentury | Feb 13, 2017
Clinical News

Researchers testing remyelination method using Schwann cells

...Scientists at San Raffaele Scientific Institute have developed a method of reprogramming skin fibroblasts into induced Schwann cells, which...
BioCentury | Nov 15, 2016
Distillery Therapeutics

Neurology

...M. et al. J. Neurosci. ; published online Oct. 12, 2016 doi:10.1523/JNEUROSCI.1643-16.2016 CONTACT: Gianvito Martino, San Raffaele Scientific Institute...
...Raffaele University, Milan, Italy email: martino.gianvito@hsr.it CONTACT: Marco Bacigaluppi, same affiliation as above email: bacigaluppi.marco@hsr.it Hongjiang Li San Raffaele Scientific Institute San...
BioCentury | Jul 9, 2015
Distillery Therapeutics

Therapeutics: Purinergic receptor P2X ligand-gated ion channel 7 (P2RX7; P2X7)

...al. Proc. Natl. Acad. Sci. USA; published online Jun. 8, 2015 doi:10.1073/pnas.1500656112 CONTACT: Guido Poli, San Raffaele Scientific Institute...
BioCentury | Jan 15, 2015
Distillery Therapeutics

Therapeutics: Metabotropic glutamate receptor subtype 1 (mGluR1; GRM1)

...published online Dec. 8, 2014; doi:10.1172/JCI74770 CONTACT: Contact: Giorgio Casari, Vita-Salute San Raffaele University and San Raffaele Scientific Institute...
Items per page:
1 - 10 of 30
BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...May 22, 2019 doi:10.1126/scitranslmed.aav7325 CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute...
BioCentury | May 29, 2018
Preclinical News

IL-1 blockade to treat CAR T side effects

...RA, giant cell arteritis and certain forms of juvenile idiopathic arthritis. Elizabeth S. Eaton Kineret, anakinra (Interleukin-1ra (IL-1ra)) San Raffaele Scientific Institute Sloan...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Neurology

...published online Feb. 20, 2018 doi:10.1016/j.celrep.2018.01.089 CONTACT: Vania Broccoli, San Raffaele Scientific Institute, Milan, Italy email: broccoli.vania@hsr.it Hongjiang Li San Raffaele Scientific Institute Optic...
BioCentury | Mar 2, 2018
Preclinical News

Targeting IL-30 could treat prostate cancer

...treating the disease. The researchers, who are based at the University of Chieti-Pescara and the San Raffaele Scientific Institute...
...normal IL-30 expression and increased metastasis to the lungs, lymph nodes and bone marrow. Jaime De Leon San Raffaele Scientific Institute Prostate...
BioCentury | Oct 23, 2017
Preclinical News

Researchers identify new targets for DMD

...27, 2015) . In a separate study , researchers at the University of Milan and San Raffaele Scientific Institute...
...and collagen deposits, and by increasing measures of muscle oxidation. Allison Johnson istaroxime Mydicar Celladon Corp. Lee's Pharmaceutical Holdings Ltd. Rutgers University San Raffaele Scientific Institute ScinoPharm...
BioCentury | Oct 3, 2017
Distillery Therapeutics

Autoimmune disease

...published online Sept. 25, 2017 doi:10.1172/JCI92387 CONTACT: Gianvito Martino, San Raffaele Scientific Institute, Milan, Italy email: martino.gianvito@hsr.it Claire Quang San Raffaele Scientific Institute Transforming...
BioCentury | Feb 13, 2017
Clinical News

Researchers testing remyelination method using Schwann cells

...Scientists at San Raffaele Scientific Institute have developed a method of reprogramming skin fibroblasts into induced Schwann cells, which...
BioCentury | Nov 15, 2016
Distillery Therapeutics

Neurology

...M. et al. J. Neurosci. ; published online Oct. 12, 2016 doi:10.1523/JNEUROSCI.1643-16.2016 CONTACT: Gianvito Martino, San Raffaele Scientific Institute...
...Raffaele University, Milan, Italy email: martino.gianvito@hsr.it CONTACT: Marco Bacigaluppi, same affiliation as above email: bacigaluppi.marco@hsr.it Hongjiang Li San Raffaele Scientific Institute San...
BioCentury | Jul 9, 2015
Distillery Therapeutics

Therapeutics: Purinergic receptor P2X ligand-gated ion channel 7 (P2RX7; P2X7)

...al. Proc. Natl. Acad. Sci. USA; published online Jun. 8, 2015 doi:10.1073/pnas.1500656112 CONTACT: Guido Poli, San Raffaele Scientific Institute...
BioCentury | Jan 15, 2015
Distillery Therapeutics

Therapeutics: Metabotropic glutamate receptor subtype 1 (mGluR1; GRM1)

...published online Dec. 8, 2014; doi:10.1172/JCI74770 CONTACT: Contact: Giorgio Casari, Vita-Salute San Raffaele University and San Raffaele Scientific Institute...
Items per page:
1 - 10 of 30